Ligand validation:5TYS

7OA: (3S,3aR,5R,7aS,8S)-hexahydro-4H-3,5-methanofuro[2,3-b]pyran-8-yl [(2S,3R)-4-[{[2-(cyclopropylamino)-1,3-benzothiazol-6-yl]sulfonyl}(2-methylpropyl)amino]-1-(3,5-difluorophenyl)-3-hydroxybutan-2-yl]carbamate

7OA is a Ligand Of Interest in 5TYS designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5TYS_7OA_A_400	69%	2%	0.14	0.956	4.84	2.17	21	20	1	0	100%	0.47
6BZ2_7OA_B_201	78%	19%	0.116	0.958	1.62	1.81	4	15	6	0	100%	0.55
6PRF_7OA_B_101	91%	58%	0.091	0.976	0.51	1.1	-	5	1	0	100%	0.5
6MKL_7OA_A_400	76%	2%	0.118	0.955	2.93	4.08	17	28	1	0	100%	0.5
7MYY_7OA_A_101	75%	59%	0.126	0.958	0.54	1.02	-	3	9	0	100%	0.5
7UE1_7OA_B_301	17%	1%	0.328	0.912	5.14	2.56	20	21	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.